REGN5459
Regeneron
['multiple myeloma']
join dr. during the promising novel antitumor strategies in early phase clinical trials oral session today at 10:15 a.m. as she shares results from a phase i/ii clinical trial for patients with relapsed or refractory multiple myeloma. #aacr23 
Indiana University Melvin and Bren Simon Comprehensive Cancer Center | The state's only NCI-designated comprehensive cancer center | A leader in cancer research